Skip to content

Earnings yield at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
Opko Health logo
Opko HealthOPK
-24.6%-29.5pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-15.3%-6.8pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
22.7%+15.1pp
ALN
Alnylam PharmaceuticalsALNY
1.1%+0.8pp
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-26.1%-10.1pp

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

Based on trailing twelve months.

The official record: MeiraGTx Holdings plc’s 10-Q, filed November 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's earnings yield?
MeiraGTx Holdings plc (MGTX) reported earnings yield of -25.5% in Q3 2025.
What is the long-term trend for MeiraGTx Holdings plc's earnings yield?
Over 3 years (2020 to 2024), MeiraGTx Holdings plc's earnings yield has grown at a 53.3% compound annual growth rate (CAGR), from -8.6% to -31.1%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.